Physician profile
Patrick R Reardon
NPI 1649270265
$13,469.93
in general payments reported to CMS, 2019-2025
8 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,648 · 2020: $8,625 · 2021: $1,804 · 2023: $94.27 · 2024: $186 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $10,478.27 | 2019-2024 | Echelon Flex, Enseal, Stratafix |
| Medline Industries LP | $1,339.59 | 2019 | |
| Medical Device Business Services, INC. | $1,308.11 | 2019-2023 | |
| Davol INC. | $145.84 | 2024 | Phasix Mesh |
| Novo Nordisk INC | $113.16 | 2025 | Wegovy, Saxenda |
| Medtronic, INC. | $62.49 | 2023 | Gi Genius |
| Tela Bio, INC. | $13.08 | 2019 | |
| Wound Management Technologies, INC | $9.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Reardon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.